Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer ; volume:06 ; number:02 ; year:2017 ; pages:047-050
South Asian journal of cancer ; 06, Heft 02 (2017), 047-050
- Beteiligte Personen und Organisationen
-
Hingmire, Sachin S.
Sambhus, Mahesh B.
Kelkar, Dhananjay S.
Joshi, Sujit
Parikh, Purvish M.
Bharath, R.
- DOI
-
10.4103/sajc.sajc_68_17
- URN
-
urn:nbn:de:101:1-2021021720433464857578
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hingmire, Sachin S.
- Sambhus, Mahesh B.
- Kelkar, Dhananjay S.
- Joshi, Sujit
- Parikh, Purvish M.
- Bharath, R.
Ähnliche Objekte (12)
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
Shorter course of trastuzumab: Caveat emptor
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V (Ablauf Befristung); Dossierbewertung
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
Shorter course of trastuzumab: Caveat emptor
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V (Ablauf Befristung); Dossierbewertung
Should MMMT still be treated with adjuvant taxane-based combination chemotherapy?
Shorter course of trastuzumab: Caveat emptor
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study
Pertuzumab/Trastuzumab (Mammakarzinom, adjuvant) : Nutzenbewertung gemäß § 35a SGB V
Trastuzumab-Related Cardiotoxicity in Adjuvant Setting: A Real-World Scenario
Combination of neoadjuvant and adjuvant chemotherapy with FOLFOX compared with adjuvant chemotherapy in management of locally advanced rectal cancers: a randomized trial of a promising therapeutic approach
Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
Adjuvant Chemotherapy for Epithelial Ovarian Cancer (EOC)
Impact of adjuvant chemotherapy for gliomatosis cerebri
Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma
Influenza vaccination in breast cancer patients during subcutaneous trastuzumab in adjuvant setting